Clicky

Nevro Corp(1N7)

Description: Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.


Keywords: Pain Chronic Pain Neurosurgery Neurotechnology Neurophysiology Neuromodulation Scs Sacroiliac Joint Spinal Cord Stimulator Stimulator

Home Page: nevro.com

1800 Bridge Parkway
Redwood City, CA 94065
United States
Phone: 650 251 0005


Officers

Name Title
Mr. Kevin R. Thornal President, CEO & Director
Mr. Roderick H. MacLeod Senior VP & CFO
Mr. Kashif Rashid J.D. Senior VP of Corporate Development & Chief Legal Officer
Mr. Greg Siller Senior VP & Chief Commercial Officer
Mr. Christofer Christoforou Senior VP & COO
Ms. Angeline C. McCabe Vice President of Investor Relations & Corporate Communications
Ms. Shana D. Ross M.B.A. Senior VP & Chief Human Resources Officer
Dr. David Caraway M.D., Ph.D. Senior VP & Chief Medical Officer
Mr. Peter A. Socarras VP, General Counsel & Corporate Secretary

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.5479
Price-to-Sales TTM: 0.3461
IPO Date:
Fiscal Year End: December
Full Time Employees: 1215
Back to stocks